The thing that baffles me the most about this whole thing is that they only found 17 companies in the OTC market with some sort of discrepancy or mis-information. If they did a clean sweep of the Pinksheets alone, they would have to suspend trading on 75% of the companies there. (That's a wild guess but you know where I'm coming from.)